申请人:Adir et Compagnie
公开号:US06127369A1
公开(公告)日:2000-10-03
A compound selected from those of formula (I): ##STR1## wherein: X represents N, C or CH, Y represents N when X represents C or CH, or Y represents C or CH when X represents N, R.sub.1 represents an optionally substituted alkyl, R.sub.2 and R.sub.3, which may be identical or different, represent Z or W, as defined in the description, their isomers and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful in the treatment of cancer.
从式(I)中选择的一种化合物:##STR1##其中:X代表N、C或CH,当X代表C或CH时,Y代表N,或者当X代表N时,Y代表C或CH,R.sub.1代表可选择地取代的烷基,R.sub.2和R.sub.3,可以相同也可以不同,代表Z或W,如所述,它们的异构体及其与药学上可接受的酸或碱形成的加合物,以及含有这种化合物的药品,这些药品对癌症的治疗是有用的。